Author Archives: Warren Woessner

Enzo Biochem V. Applera Corp. – When “Words Can Hurt You”

Posted on March 19, 2015 by Warren Woessner

On March 16, 2015 (Appeal no. 2014-1321), the Fed. Cir. reversed the district court’s construction of a claim term relating to the scope of “A,” a moiety capable of direct or indirect signaling that is attached by a linker to … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Applera Corp, biotechnology, biotechnology law, Enzo Biochem, Federal Circuit, intellectual property, ip, Warren Woessner | Leave a comment

Takeaways from Chisum Patent Academy 2015 Seminar in Cincinnati

Posted on March 11, 2015 by Warren Woessner

Guest Post from Don Chisum On March 5-6, 2015 the Chisum Patent Academy held a two-day seminar at the 21C Museum Hotel in downtown Cincinnati, Ohio to discuss and debate current developments in U.S. patent law. The roundtable seminar group … Continue reading →

Posted in Conferences and Classes, Uncategorized | Tagged biotechnology law, Don Chisum, intellectual property, ip, IP law tools, Patent Law, patents, Warren Woessner | Leave a comment

Novartis Wins Landmark Biosimilar Approval

Posted on March 9, 2015 by Warren Woessner

Novartis Navigates The FDA-ACA Maze – Gets Approval For Generic Neuprogen. Amgen will soon find itself in a price war with Sandoz – a Novartis company – as it tries to maintain its share of the market for Neuprogen (filgraslim). … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Amgen, biotechnology, Federal Circuit, intellectual property, ip, Neuprogen, Novartis, Sandoz, Warren Woessner | Leave a comment

Patents4Life is Six Years Old this Month. Happy Birthday to Us!

Posted on March 3, 2015 by Warren Woessner

Six years ago, In re Kubin caused a flurry of concern among biotech practitioners, and a short article on this decision was the first post on Patents4Life. That was a pretty big “story” at the time but we all had … Continue reading →